ADC Therapeutics SA (ADCT)

ADC Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	278.6	326.44	466.54	439.2	115.55
Cash & Cash Equivalents	278.6	326.44	466.54	439.2	115.55
Cash Growth	-14.66%	-30.03%	6.23%	280.09%	-16.75%
Receivables	25.18	72.97	30.22	0	0
Inventory	16.18	12.07	11.12	0	0
Other Current Assets	16.33	23.5	17.3	11.26	7.06
Total Current Assets	336.29	434.98	525.18	450.45	122.61
Property, Plant & Equipment	16.13	10.26	11.23	4.76	6.27
Long-Term Investments	1.65	7.61	41.24	47.91	0
Goodwill and Intangibles	0	0	13.58	10.18	8.43
Other Long-Term Assets	0.71	38.01	26.74	0.4	0.37
Total Long-Term Assets	18.49	55.88	92.79	63.24	15.08
Total Assets	354.78	490.86	617.97	513.69	137.68
Accounts Payable	15.57	12.35	12.08	5.28	3.33
Current Debt	0	1.1	7.6	4.63	1.13
Other Current Liabilities	52.1	68.49	54.25	30.52	15.48
Total Current Liabilities	67.67	81.94	73.94	40.44	19.94
Long-Term Debt	122.91	116.28	132.09	110.45	3.9
Other Long-Term Liabilities	312.45	213.19	245.86	27.3	2.68
Total Long-Term Liabilities	435.36	329.47	377.95	137.75	6.58
Total Liabilities	503.03	411.41	451.88	178.19	26.53
Total Debt	122.91	117.38	139.7	115.08	5.03
Debt Growth	4.72%	-15.98%	21.39%	2187.44%	-
Retained Earnings	-1,335.47	-1,095.42	-924.89	-694.86	-448.57
Comprehensive Income	-0.09	1.82	0.18	0.25	0.07
Shareholders' Equity	-148.25	79.45	166.09	335.51	111.16
Net Cash / Debt	155.69	209.07	326.85	324.11	110.52
Net Cash / Debt Growth	-25.53%	-36.04%	0.84%	193.26%	-20.38%
Net Cash Per Share	1.91	2.68	-	-	-
Working Capital	268.62	353.04	451.25	410.01	102.66
Book Value Per Share	-1.81	1.02	2.16	4.73	1.66

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).